Abstract:One of the critical responsibilities of cosmetic and personal care industry is to determine the safety profile of the ingredients and/or formulations before launching new products on the market for consumers’ use. While products manufactured by other industries are thoroughly regulated (pharmaceuticals, pesticides, etc.), the safety assessment of cosmetic and personal care products seems to be less strictly integrated in the regulatory framework, despite the fact that the type of testing methods allowed for use became more restrictive in recent years. As such, a ban on animal testing of cosmetic ingredients and final formulations in the European Union (EU) took effect between 2009 and 2013. Thereon, industry used testing strategies based on nonanimal methods that were often designed to assess the safety profile of specific product lines. A diverse range of in vitro methods is now available and considered suitable to provide reliable interpretation of the safety data regarding ingredients used in finished cosmetic and personal care products. These methods range from simple cell monoculture test systems to more complex such as explants or three-dimensional reconstructed organotypic tissue models. This chapter discusses the use of several in vitro methods in the preclinical safety assessment of skin care products with special emphasis on skin irritation and sensitization endpoints.

Application of In Vitro Methods in Preclinical Safety Assessment of Skin Care Products